{"database": "lobbying", "table": "lobbying_activities", "rows": [[1295878, "bb182dfd-9884-4d89-af3f-543242081c85", "Q3", "AGILENT TECHNOLOGIES, INC", 54051, "AGILENT TECHNOLOGIES INC", 2012, "third_quarter", "CHM", "S. 847, Safe Chemicals Act of 2011, Section 30. Reduction of Animal-Based Testing.\nH.R. 2521 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011, Title I, Research on Endocrine-Disrupting Chemicals\nS.1361 Endocrine Disrupting Chemicals Exposure Elimination Act of 2011, Title I, Research on Endocrine-Disrupting Chemicals", "Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE", null, 9864, 0, 0, "2012-10-08T16:10:09.687000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1295878"], "units": {}, "query_ms": 38.76264701830223, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}